Cyfuse Biomedical K.K. (TYO:4892)
Japan · Delayed Price · Currency is JPY 664.00
-6.00 (-0.90%)
Sep 16, 2026, 3:30 PM JST
Cyfuse Biomedical K.K. Market Cap
Cyfuse Biomedical K.K. has a market cap or net worth of 6.68 billion as of September 15, 2026. Its market cap has increased by 37.65% in one year.
Market Cap
6.68B
Enterprise Value
4.52B
Revenue
305.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
664.00
ChartMarket Cap Chart
Since December 1, 2022, Cyfuse Biomedical K.K.'s market cap has decreased from 13.00B to 6.68B, a decrease of -48.66%. That is a compound annual growth rate of -16.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 6.68B | 17.72% |
| Dec 30, 2025 | 5.67B | 54.23% |
| Dec 30, 2024 | 3.68B | -38.27% |
| Dec 29, 2023 | 5.96B | -37.68% |
| Dec 30, 2022 | 9.56B | -26.49% |
| Dec 1, 2022 | 13.00B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 7.92B |
| StemCell Institute | 7.53B |
| ADR Biomedical Holdings | 7.46B |
| Chiome Bioscience | 6.87B |
| SUSMED,Inc. | 6.84B |
| MEDINET | 6.78B |
| CellSource | 6.43B |
| PRISM BioLab Co.,LTD | 6.14B |